These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3746260)
21. Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells. Repges-Illguth S; Kaluza G Arch Virol; 1994; 135(3-4):433-5. PubMed ID: 7526823 [TBL] [Abstract][Full Text] [Related]
23. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2. Kaluza G; Repges S; McDowell W Virology; 1990 Jun; 176(2):369-78. PubMed ID: 1693245 [TBL] [Abstract][Full Text] [Related]
24. Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report. Boere WA; Harmsen M; Kraaijeveld CA; Snippe H Arch Virol; 1986; 88(1-2):105-12. PubMed ID: 2420309 [TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus. Kraaijeveld CA; Benaissa-Trouw BJ; Harmsen M; Snippe H Arch Virol; 1986; 91(1-2):83-92. PubMed ID: 3489451 [TBL] [Abstract][Full Text] [Related]
27. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines. Fernández IM; Harmsen M; Benaissa-Trouw BJ; Stuij I; Puyk W; Meloen RH; Snippe H; Kraaijeveld CA Vaccine; 1998 Oct; 16(16):1531-6. PubMed ID: 9711800 [TBL] [Abstract][Full Text] [Related]
28. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus. Dimmock NJ; Kennedy SI J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175 [TBL] [Abstract][Full Text] [Related]
29. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus. Barrett AD; Dimmock NJ J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774 [TBL] [Abstract][Full Text] [Related]
30. Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine. Pinto AA; Garland AJ J Hyg (Lond); 1979 Feb; 82(1):41-50. PubMed ID: 216744 [TBL] [Abstract][Full Text] [Related]
31. The Semliki Forest virus E2 gene as a virulence determinant. Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541 [TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. Brand D; Lemiale F; Turbica I; Buzelay L; Brunet S; Barin F AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1369-77. PubMed ID: 9788678 [TBL] [Abstract][Full Text] [Related]
33. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice. Crouch CF; Mackenzie A; Dimmock NJ J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798 [TBL] [Abstract][Full Text] [Related]
34. Simple method for preparation of immune sera to envelope and nucleocapsid antigens of Semliki Forest virus. Gaidamovich SY; Melnikova EE; Krasnobaeva ZN Acta Virol; 1977 Jul; 21(4):347-8. PubMed ID: 20771 [TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of Vero-cell infectious bursal disease vaccine in Pakistan. Rasool MH; Hussain I Vaccine; 2006 Apr; 24(15):2810-4. PubMed ID: 16490290 [TBL] [Abstract][Full Text] [Related]
36. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Zhou X; Berglund P; Zhao H; Liljeström P; Jondal M Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3009-13. PubMed ID: 7708765 [TBL] [Abstract][Full Text] [Related]
37. A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production. Snijders A; Benaissa-Trouw BJ; Visser-Vernooy HJ; Fernandez I; Snippe H; Kraaijeveld CA Immunology; 1992 Nov; 77(3):322-9. PubMed ID: 1282493 [TBL] [Abstract][Full Text] [Related]
38. Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus. Stebbing N; Lindley IJ Arch Virol; 1980; 64(1):57-66. PubMed ID: 6246856 [TBL] [Abstract][Full Text] [Related]
39. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication. Barrett AD; Guest AR; Mackenzie A; Dimmock NJ J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709 [TBL] [Abstract][Full Text] [Related]
40. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]